News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Xamiol(R) - LEO Pharma’s New Drug for the Treatment of Scalp Psoriasis - is Approved in Europe
August 19, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BALLERUP, Denmark--(BUSINESS WIRE)--Xamiol® – LEO Pharma’s new drug for treatment of scalp psoriasis – has been approved in 16 European countries.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
·
5 min read
·
Annalee Armstrong
Artificial intelligence
Amid Layoffs, Delays, FDA Turns to AI for Speedy Reviews
May 9, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Delays Continue as Regulator Misses Review Date for GSK’s Nucala
May 9, 2025
·
2 min read
·
Tristan Manalac
Special edition
Deep Dive: Biopharma In Turmoil As Peter Marks Forced Out of FDA
May 9, 2025
·
2 min read
·
Annalee Armstrong
